Money
Eli Lilly's CEO Critiques White House Drug Pricing Reform Efforts
Eli Lilly's leadership has expressed clear opposition to the White House's initiative to codify drug pricing reforms, particularly the 'most favored nation' proposal.
Editorial Staff 5 days ago